中国肾脏移植长期健康管理指南(2023版)  

Guideline for long-term health management after kidney transplantation in China(2023 edition)

作　　者：中华医学会器官移植学分会 中国医疗保健国际交流促进会肾脏移植学分会 张伟杰[2] 薛武军[3] Branch of Organ Transplantation,Chinese Medical Association;Kidney Transplantation Branch of China International Exchange and Promotive Association for Medical and Health Care

机构地区：[1]不详 [2]华中科技大学同济医学院附属同济医院器官移植研究所,武汉430000 [3]西安交通大学第一附属医院肾脏病医院肾移植科,西安710006

出　　处：《中华器官移植杂志》2024年第5期283-298,共16页Chinese Journal of Organ Transplantation

基　　金：湖北省重点研发计划 (2022BCA015)。

摘　　要：肾脏移植受者术后需终身服用免疫抑制剂,容易出现排斥反应、感染、心血管疾病等多种并发症,影响移植物的长期存活。为进一步规范中国肾脏移植受者术后长期健康管理,中华医学会器官移植学分会组织移植领域相关专家以国内外临床证据为基础,总结了肾脏移植受者的一般医疗管理,包括移植肾功能的监测和受者的依从性、疫苗接种、矿物质和骨代谢异常、饮食、运动、心理健康等常见问题,制定了肾脏移植长期健康管理指南,以帮助移植工作者规范和优化移植受者的长期健康管理。Kidney transplantation(KT)recipients are obliged to take immunosuppressants for a long time.Many complications of rejection,infection and cardiovascular disease may affect the long-term survival outcome of graft.To further standardize the long-term health management of kidney transplant recipients in China,the relevant experts were convened by Society of Organ Transplantation of China Medical Association for formulating the standards for long-term health management after KT.Based upon domestic and foreign clinical evidence,this guideline focused upon the monitoring of graft kidney function and common issues such as recipient compliance,vaccination,mineral and bone metabolism abnormalities,diet,exercise and mental health.

关 键 词：肾脏移植 健康管理 随访 排斥反应 依从性 糖耐量减低 

分 类 号：R699.2[医药卫生—泌尿科学]